These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23974417)

  • 1. Equipment, supplies, and facilites required for hospital compounding.
    McElhiney LF
    Int J Pharm Compd; 2006; 10(6):436-41. PubMed ID: 23974417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Records and record-keeping for the hospital compounding pharmacist.
    McElhiney LF
    Int J Pharm Compd; 2007; 11(2):136-41. PubMed ID: 23974620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survey of sterile product compounding practices in Canadian hospital pharmacies.
    Fitch DP; Hall KW
    Can J Hosp Pharm; 1993 Dec; 46(6):249-60. PubMed ID: 10131343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 4: considerations in selection and use of disinfectants and antiseptics.
    Allen LV; Okeke CC
    Int J Pharm Compd; 2007; 11(6):492-9. PubMed ID: 23994811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basics of compounding: the responsibilities of compounding personnel in implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 2.
    Allen LV; Okeke CC
    Int J Pharm Compd; 2007; 11(4):313-23. PubMed ID: 23974791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Education, training, and evaluation of hospital compounding personnel.
    McElhiney LF
    Int J Pharm Compd; 2006; 10(5):361-8. PubMed ID: 23974315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding medication compounding issues.
    Hicks RW
    AORN J; 2014 Apr; 99(4):466-76; quiz 477-9. PubMed ID: 24674793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mayo Clinic approaches to meet United States Pharmacopeia <797> requirements for facility design and environmental controls of nuclear pharmacy.
    Hung JC; Anderson MM
    J Nucl Med; 2009 Jan; 50(1):156-64. PubMed ID: 19091891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survey of sterile admixture practices in canadian hospital pharmacies: part 2. More results and discussion.
    Warner T; Nishi C; Checkowski R; Hall KW
    Can J Hosp Pharm; 2009 May; 62(3):192-203. PubMed ID: 22478890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survey of sterile admixture practices in canadian hospital pharmacies: part 1. Methods and results.
    Warner T; Nishi C; Checkowski R; Hall KW
    Can J Hosp Pharm; 2009 Mar; 62(2):100-11. PubMed ID: 22478875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of United States pharmacopeia chapter 795 and american society of health-system pharmacists guidelines for nonsterile compounding.
    McElhiney LF
    Int J Pharm Compd; 2009; 13(6):525-30. PubMed ID: 23965326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 8: stability and beyond-use dating.
    Allen LV; Okeke CC
    Int J Pharm Compd; 2008; 12(4):344-53. PubMed ID: 23969772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacy compounding of high-risk level products and patient safety.
    Mullarkey T
    Am J Health Syst Pharm; 2009 Sep; 66(17 Suppl 5):S4-13. PubMed ID: 19710449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Validation of aseptic technique of parenteral nutrition compounding in a pharmacy service according to USP Chapter 797].
    Romero Jiménez RM; Pernía López MS; Sánchez Fresneda MN; Sanjurjo Sáez M
    Nutr Hosp; 2013; 28(5):1494-7. PubMed ID: 24160206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sterile Basics of Compounding: Particulates in Parenteral Preparations: Sources, Minimization, and Detection.
    Allen LV
    Int J Pharm Compd; 2022; 26(3):219-228. PubMed ID: 35657746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations.
    Okeke CC; Allen LV
    Int J Pharm Compd; 2010; 14(1):60-4. PubMed ID: 23965372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National survey of quality assurance activities for pharmacy-compounded sterile preparations.
    Morris AM; Schneider PJ; Pedersen CA; Mirtallo JM
    Am J Health Syst Pharm; 2003 Dec; 60(24):2567-76. PubMed ID: 14735774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 5: verification of accuracy, sterility, and sterilization of compounded preparations.
    Allen LV; Okeke CC
    Int J Pharm Compd; 2008; 12(1):54-60. PubMed ID: 23969573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Teaching lab renovation: university of Texas at austin college of pharmacy combines sterile and nonsterile compounding lab spaces.
    Acosta WR; Salzman RD
    Int J Pharm Compd; 2006; 10(4):277-80. PubMed ID: 23974259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 7: microbial contamination risk levels, 12-hour use, and immediate use.
    Allen LV; Okeke CC
    Int J Pharm Compd; 2008; 12(3):252-7. PubMed ID: 23969716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.